Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motohiko Tanaka

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Bioscience Trends|December 20, 2016
Ledipasvir and sofosbuvir for recurrent hepatitis C after liver transplantationYuki Oya, Yasuhiko Sugawara, Takehisa Watanabe, et al.
BMC Gastroenterology|November 10, 2020
Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control studyMasakuni Tateyama, Hideaki Naoe, Motohiko Tanaka, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2014
Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nanoantioxidant for treatment of two acute hepatitis modelsHitoshi Maeda, Kenshiro Hirata, Hiroshi Watanabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 22, 2016
Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantationMasaki Honda, Yasuhiko Sugawara, Takehisa Watanabe, et al.
DEN Open|October 30, 2023
Clinical usefulness of inside stents in anastomotic biliary strictures after liver transplantationNaotaka Kugiyama, Shunpei Hashigo, Katsuya Nagaoka, et al.
Cancers|March 11, 2023
Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular CarcinomaTakayuki Tokunaga, Masakuni Tateyama, Yasuteru Kondo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 29, 2023
Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinomaYoko Yoshimaru, Katsuya Nagaoka, Kentaro Tanaka, et al.
Hepatology Communications|November 27, 2021
Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular CarcinomaSatoshi Narahara, Takehisa Watanabe, Katsuya Nagaoka, et al.
Surgery Today|November 8, 2017
Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinomaHideaki Takeyama, Toru Beppu, Takaaki Higashi, et al.
Case Reports in Oncology|June 7, 2013
Pancreatic metastasis from mixed adenoneuroendocrine carcinoma of the uterine cervix: a case reportChihiro Nishimura, Hideaki Naoe, Shunpei Hashigo, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Bioscience Trends|December 20, 2016
Ledipasvir and sofosbuvir for recurrent hepatitis C after liver transplantationYuki Oya, Yasuhiko Sugawara, Takehisa Watanabe, et al.
BMC Gastroenterology|November 10, 2020
Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control studyMasakuni Tateyama, Hideaki Naoe, Motohiko Tanaka, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2014
Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nanoantioxidant for treatment of two acute hepatitis modelsHitoshi Maeda, Kenshiro Hirata, Hiroshi Watanabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 22, 2016
Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantationMasaki Honda, Yasuhiko Sugawara, Takehisa Watanabe, et al.
DEN Open|October 30, 2023
Clinical usefulness of inside stents in anastomotic biliary strictures after liver transplantationNaotaka Kugiyama, Shunpei Hashigo, Katsuya Nagaoka, et al.
Cancers|March 11, 2023
Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular CarcinomaTakayuki Tokunaga, Masakuni Tateyama, Yasuteru Kondo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 29, 2023
Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinomaYoko Yoshimaru, Katsuya Nagaoka, Kentaro Tanaka, et al.
Hepatology Communications|November 27, 2021
Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular CarcinomaSatoshi Narahara, Takehisa Watanabe, Katsuya Nagaoka, et al.
Surgery Today|November 8, 2017
Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinomaHideaki Takeyama, Toru Beppu, Takaaki Higashi, et al.
Case Reports in Oncology|June 7, 2013
Pancreatic metastasis from mixed adenoneuroendocrine carcinoma of the uterine cervix: a case reportChihiro Nishimura, Hideaki Naoe, Shunpei Hashigo, et al.
Pageof 5